Freenome, Inc.FRNM
Cash in trust
$85.1M
$85,086,232
Trust per share
$9.87
Redemption value
IPO
Jun 2024
$84.5M raised
Combination deadline
—
Not disclosed
Filings on record
134
Latest Oct 20, 2026
Business combination
- Target
- Not disclosed in an indexed filing
- Announced
- Dec 5, 2025
- Closed
- Jul 24, 2026
Overview
Freenome, Inc. is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0002017526. It completed its initial public offering in Jun 2024, raising $84.5M in gross proceeds and listing on Nasdaq. Class A shares trade under the ticker FRNM on Nasdaq. The vehicle is sponsored by Freenome. The mandate targets healthcare. Business combination closed; the company trades under a new ticker.
“we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries.”
Reading the filings
Arithmetic on what Freenome, Inc. has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.
Trust versus the $10 unit
The trust holds $9.87 per public share, below the $10.00 unit price. A trust that has fallen under the offering price usually means charges against it or a restatement, so read the most recent quarterly report before relying on the figure.
Sponsor record
Freenome has launched 2 vehicles. Of the 2 that have resolved, 2 closed a combination and 0 liquidated, a 100% completion rate. A sponsor's record is not a forecast, but it does tell you whether the team has taken a deal across the line before.
Underwriting
Jefferies led the offering. It has been named on 73 SPAC IPOs, book-running 68 of them, and 53.1% of its resolved vehicles closed a deal. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.
Filings per month since the first one. A vehicle that has gone quiet with a deadline ahead is a different proposition from one that is still working.
134 filings in all. 14 in the last three months, against a busiest month of 39.
News on Freenome, Inc.
Last 90 days- Neutral
- Freenome: SimpleScreen CRC Unlocks A 50M Patient TAM, Bypassing CompetitionNeutral
SeekingAlpha · 29d ago
News sentiment
NeutralAcross 5 recent stories, weighted towards the newest. Scored by our own headline classifier using finance- and SPAC-specific terms. It reads what a story is about, not what the shares are worth.
SEC filing history
Free tier: filings older than 24 hours- 424B3
Prospectus supplement
Accession 0001140361-26-040191
- 8-K
Regulation FD disclosure; Other events
Items 7.01, 8.01, 9.01 · Accession 0001140361-26-040186
- S-8
S-8
Accession 0001140361-26-037448
- 4
Statement of changes in beneficial ownership
Accession 0001140361-26-035816
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001104659-26-104335
- EFFECT
Notice of effectiveness
Accession 9999999995-26-002784
- 424B3
Prospectus supplement
Accession 0001140361-26-034715
- S-1
Registration statement for the initial public offering
Accession 0001140361-26-033585
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001104659-26-097320
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0000919574-26-005344
- 8-K/A
Completion of an acquisition
Items 2.01, 9.01 · Accession 0001140361-26-032873
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0000919574-26-005023
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001404574-26-000022
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0002053305-26-000005
- EFFECT
Notice of effectiveness
Accession 9999999995-26-002487
- 4
Statement of changes in beneficial ownership
Accession 0001449008-26-000004
- POS AM
POS AM
Accession 0001140361-26-029907
- 3
Initial statement of beneficial ownership
Accession 0001140361-26-029810
- 3
Initial statement of beneficial ownership
Accession 0001140361-26-029809
- 3
Initial statement of beneficial ownership
Accession 0001140361-26-029808
- 3
Initial statement of beneficial ownership
Accession 0001140361-26-029812
- 3
Initial statement of beneficial ownership
Accession 0001140361-26-029807
- 3
Initial statement of beneficial ownership
Accession 0001140361-26-029806
- 3
Initial statement of beneficial ownership
Accession 0001140361-26-029811
- 3
Initial statement of beneficial ownership
Accession 0001140361-26-029805
- 3
Initial statement of beneficial ownership
Accession 0001140361-26-029804
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001656629-26-000002
- 8-K
Regulation FD disclosure; Other events
Items 7.01, 8.01, 9.01 · Accession 0001140361-26-029689
- 4
Statement of changes in beneficial ownership
Accession 0001602787-26-000004
- POS AM
POS AM
Accession 0001140361-26-029472
Pro
Track FRNM without the delay
Free accounts see this filing history a day late. Pro shows every document minutes after EDGAR publishes it, opens it on EDGAR in one click, and adds the twelve-month deadline calendar.
- Filings live, no 24-hour delay
- One click through to the source document
- Deadline calendar out to 12 months
- CSV export, API and MCP access
Cancel any time. Billed monthly in USD.
Freenome, Inc.: questions answered
What is Freenome, Inc. (FRNM)?
Freenome, Inc. is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0002017526. It completed its initial public offering in Jun 2024, raising $84.5M in gross proceeds and listing on Nasdaq. Class A shares trade under the ticker FRNM on Nasdaq. The vehicle is sponsored by Freenome. The mandate targets healthcare. Business combination closed; the company trades under a new ticker.
How much does Freenome, Inc. hold in trust?
Approximately $85,086,232, or about $9.87 per public share, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.
When must Freenome, Inc. complete a merger?
No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.
What happens if Freenome, Inc. does not find a target in time?
The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.
Can I redeem shares in Freenome, Inc., and at what price?
Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date, most recently disclosed at about $9.87 per share. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.
What tickers does Freenome, Inc. trade under?
Class A shares trade as FRNM on Nasdaq. Units trade first and separate into their component securities roughly 52 days after the IPO; only the Class A shares carry the redemption right against the trust.
Is the trust value the same as the share price for Freenome, Inc.?
No, and the gap between them is the whole trade. Trust per share is a disclosed, contractual figure of $9.87, being what a redeeming holder receives. The market price is whatever the shares change hands at: most recently $14.01, a spread to the redemption value. Quotes on this site are delayed and indicative; confirm on your own venue before trading.
Who sponsors Freenome, Inc., and what is their track record?
Freenome is the sponsor entity, part of the Freenome franchise. That franchise has launched 2 vehicles in total, of which 2 closed a combination and 0 liquidated, a 100% completion rate on resolved vehicles. Named principals: Adam Stone, Joseph Edelman.
Which banks underwrote the Freenome, Inc. IPO?
Jefferies. Jefferies was credited as book-running manager on the cover. Syndicate membership and role are read from the prospectus cover and the underwriting section.
Is Freenome, Inc. tradeable, and where?
Yes. FRNM returned a live quote of $14.01 on Nasdaq. Quotes here are delayed and refreshed on a schedule rather than streamed, so treat the figure as indicative and confirm on your own venue. Units and warrants trade under their own symbols and are quoted separately.
Is Freenome, Inc. a good investment?
That is not a question this site answers. Freenome, Inc. is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.
Where does this Freenome, Inc. data come from?
Filings Freenome, Inc. submitted to the SEC under CIK 0002017526: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.
Compiled by the SPACListing research desk
Last reconciled Oct 21, 2026
Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.
Read the full methodology · What is in the dataset · Report a correction
SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.
Continue reading
The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.
Freenome: the full record
Every vehicle this sponsor has launched, what closed, what liquidated and what is still live.
Jefferies in SPACs
Mandates, bookrun credit, deal volume and the outcome of the vehicles it priced.
Healthcare SPACs
Every vehicle chasing the same mandate, ranked by cash in trust.
All completed de-spac transactions
Business combination closed; the company trades under a new ticker.
Deadline calendar
Which sponsors are running out of time, and when the extension votes land.
What is a SPAC?
The structure, the economics and where the risks actually sit.
SPAC glossary
Every term in a blank-check filing, defined the way practitioners use it.
How this data is built
Coverage universe, ingestion, normalisation, lifecycle classification and known limits.